TrademarkDir
Serial #98404839
LIVE

Serial Number

98404839

Owner

Neurocrine Biosciences, Inc.

Attorney

Allison Strickland Ricketts

Filing Date

Feb 14, 2024

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

Serial #98404839 Trademark

Serial Number: 98404839

Serial #98404839 is a trademark filed by Neurocrine Biosciences, Inc. on February 14, 2024. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Neurocrine Biosciences, Inc. (237 trademarks)

6027 Edgewood Bend Court
San Diego, CA 92130

Entity Type: 03

Trademark Details

Filing Date

February 14, 2024

Registration Date

Not Registered

Published for Opposition

March 11, 2025

Goods & Services

providing medical research information; providing medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia and other endocrine diseases and disorders; Conducting clinical trials for pharmaceutical preparations for the treatment of congenital adrenal hyperplasia and other endocrine diseases and disorders; conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results

providing medical information; providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders; on-line information services, namely, providing medical information to patients, medical professionals in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 30, 2026 EXRA
SOU EXTENSION 2 GRANTED
Apr 29, 2026 EX2G
SOU EXTENSION 2 FILED
Apr 28, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 28, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 14, 2025 EXRA
SOU EXTENSION 1 GRANTED
Nov 13, 2025 EX1G
SOU EXTENSION 1 FILED
Nov 6, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 6, 2025 EEXT
CORRECTED NOA E-MAILED
Nov 5, 2025 NOAC
DIVISIONAL PROCESSING COMPLETE
Nov 5, 2025 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 4, 2025 AITU
DIVISIONAL REQUEST RECEIVED
Aug 21, 2025 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Aug 21, 2025 ERTD
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 6, 2025 NOAM
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 20, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 20, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 20, 2025 COAR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 5, 2025 NONP
ASSIGNED TO LIE
Feb 14, 2025 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 12, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 7, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 7, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 7, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 27, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 27, 2024 XELR
NOTIFICATION OF PRIORITY ACTION E-MAILED
Aug 15, 2024 GPRN
PRIORITY ACTION E-MAILED
Aug 15, 2024 GPRA
PRIORITY ACTION WRITTEN
Aug 15, 2024 CPRA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 31, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 31, 2024 XELR
NOTIFICATION OF PRIORITY ACTION E-MAILED
May 30, 2024 GPRN
PRIORITY ACTION E-MAILED
May 30, 2024 GPRA
PRIORITY ACTION WRITTEN
May 30, 2024 CPRA
ASSIGNED TO EXAMINER
May 22, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 5, 2024 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 5, 2024 NWOS
NEW APPLICATION ENTERED
Feb 14, 2024 NWAP

Related Trademarks

More from this Owner

DISCOVER CRENESSITY

DISCOVER CRENESSITY

DISCOVERCAH

DISCOVERCAH

THE SCIENCE OF FEELING ALIVE

THE SCIENCE OF FEELING ALIVE

GC OPTIMIZE

GC OPTIMIZE

NEUROCRINE

NEUROCRINE

MAKE THE SCREEN ROUTINE

MAKE THE SCREEN ROUTINE